First Time Loading...
A

Adagio Therapeutics Inc
NASDAQ:ADGI

Watchlist Manager
Adagio Therapeutics Inc
NASDAQ:ADGI
Watchlist
Price: 3.48 USD -3.33% Market Closed
Updated: May 3, 2024

Income Statement

Earnings Waterfall
Adagio Therapeutics Inc

Revenue
0 USD
Operating Expenses
-230.7m USD
Operating Income
-230.7m USD
Other Expenses
-10.7m USD
Net Income
-241.3m USD

Income Statement
Adagio Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2020 Dec-2021 Dec-2022
Revenue
Revenue
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(65)
(227)
(231)
Selling, General & Administrative
(3)
(37)
(47)
Research & Development
(62)
(190)
(184)
Operating Income
(65)
N/A
(227)
-247%
(231)
-2%
Pre-Tax Income
Interest Income Expense
0
2
4
Total Other Income
0
(2)
(15)
Pre-Tax Income
(65)
N/A
(227)
-247%
(241)
-6%
Net Income
Income from Continuing Operations
(65)
(227)
(241)
Net Income (Common)
(65)
N/A
(227)
-247%
(241)
-6%
EPS (Diluted)
-0.6
N/A
-5.32
-787%
-2.23
+58%

See Also

Discover More